MultiStem Cell Therapy Treatment

MultiStem Cell Therapy Treatment

Athersys

Category

Laboratory

Country

United States of America (USA), North America

Description

Athersys is to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome